Report Detail
Global Multi-Cancer Detection Blood Test Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4556747 |
- 17 September, 2023 |
- Global |
- 107 Pages |
- GIR (Global Info Research) |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Multi-Cancer Detection Blood Test market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Multi-Cancer Detection Blood Test, also known as a liquid biopsy or pan-cancer test, is a type of medical test that aims to detect multiple types of cancer in the body using a blood sample. Unlike traditional cancer screenings that focus on specific cancer types, this test is designed to provide a more comprehensive assessment by detecting various cancer-related biomarkers or genetic alterations present in the bloodstream.
The Multi-Cancer Detection Blood Test holds promise for early cancer detection, as it can potentially identify cancers at an earlier stage when treatment options are more effective and outcomes are better. It may also aid in monitoring cancer patients during treatment and post-treatment to detect recurrence or treatment response.
The Global Info Research report includes an overview of the development of the Multi-Cancer Detection Blood Test industry chain, the market status of Hospitals (ctDNA-Based Tests, Protein Biomarker-Based Tests), Diagnostic Laboratories (ctDNA-Based Tests, Protein Biomarker-Based Tests), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Multi-Cancer Detection Blood Test.
Regionally, the report analyzes the Multi-Cancer Detection Blood Test markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Multi-Cancer Detection Blood Test market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Multi-Cancer Detection Blood Test market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Multi-Cancer Detection Blood Test industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., ctDNA-Based Tests, Protein Biomarker-Based Tests).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Multi-Cancer Detection Blood Test market.
Regional Analysis: The report involves examining the Multi-Cancer Detection Blood Test market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Multi-Cancer Detection Blood Test market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Multi-Cancer Detection Blood Test:
Company Analysis: Report covers individual Multi-Cancer Detection Blood Test manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Multi-Cancer Detection Blood Test This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostic Laboratories).
Technology Analysis: Report covers specific technologies relevant to Multi-Cancer Detection Blood Test. It assesses the current state, advancements, and potential future developments in Multi-Cancer Detection Blood Test areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Multi-Cancer Detection Blood Test market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Multi-Cancer Detection Blood Test market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
ctDNA-Based Tests
Protein Biomarker-Based Tests
Methylation-Based Tests
Others
Market segment by Application
Hospitals
Diagnostic Laboratories
Others
Major players covered
Galleri
Amadix
Burning Rock
Exact Sciences
Freenome
AnchorDx
Guardant Health
Foundation Medicine
GENECAST
Coyne Medical
Laboratory for Advanced Medicine
Singlera Genomics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Multi-Cancer Detection Blood Test product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Multi-Cancer Detection Blood Test, with price, sales, revenue and global market share of Multi-Cancer Detection Blood Test from 2018 to 2023.
Chapter 3, the Multi-Cancer Detection Blood Test competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Multi-Cancer Detection Blood Test breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Multi-Cancer Detection Blood Test market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Multi-Cancer Detection Blood Test.
Chapter 14 and 15, to describe Multi-Cancer Detection Blood Test sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Multi-Cancer Detection Blood Test
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Multi-Cancer Detection Blood Test Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 ctDNA-Based Tests
- 1.3.3 Protein Biomarker-Based Tests
- 1.3.4 Methylation-Based Tests
- 1.3.5 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Multi-Cancer Detection Blood Test Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospitals
- 1.4.3 Diagnostic Laboratories
- 1.4.4 Others
- 1.5 Global Multi-Cancer Detection Blood Test Market Size & Forecast
- 1.5.1 Global Multi-Cancer Detection Blood Test Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Multi-Cancer Detection Blood Test Sales Quantity (2018-2029)
- 1.5.3 Global Multi-Cancer Detection Blood Test Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Galleri
- 2.1.1 Galleri Details
- 2.1.2 Galleri Major Business
- 2.1.3 Galleri Multi-Cancer Detection Blood Test Product and Services
- 2.1.4 Galleri Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Galleri Recent Developments/Updates
- 2.2 Amadix
- 2.2.1 Amadix Details
- 2.2.2 Amadix Major Business
- 2.2.3 Amadix Multi-Cancer Detection Blood Test Product and Services
- 2.2.4 Amadix Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Amadix Recent Developments/Updates
- 2.3 Burning Rock
- 2.3.1 Burning Rock Details
- 2.3.2 Burning Rock Major Business
- 2.3.3 Burning Rock Multi-Cancer Detection Blood Test Product and Services
- 2.3.4 Burning Rock Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Burning Rock Recent Developments/Updates
- 2.4 Exact Sciences
- 2.4.1 Exact Sciences Details
- 2.4.2 Exact Sciences Major Business
- 2.4.3 Exact Sciences Multi-Cancer Detection Blood Test Product and Services
- 2.4.4 Exact Sciences Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Exact Sciences Recent Developments/Updates
- 2.5 Freenome
- 2.5.1 Freenome Details
- 2.5.2 Freenome Major Business
- 2.5.3 Freenome Multi-Cancer Detection Blood Test Product and Services
- 2.5.4 Freenome Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Freenome Recent Developments/Updates
- 2.6 AnchorDx
- 2.6.1 AnchorDx Details
- 2.6.2 AnchorDx Major Business
- 2.6.3 AnchorDx Multi-Cancer Detection Blood Test Product and Services
- 2.6.4 AnchorDx Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 AnchorDx Recent Developments/Updates
- 2.7 Guardant Health
- 2.7.1 Guardant Health Details
- 2.7.2 Guardant Health Major Business
- 2.7.3 Guardant Health Multi-Cancer Detection Blood Test Product and Services
- 2.7.4 Guardant Health Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Guardant Health Recent Developments/Updates
- 2.8 Foundation Medicine
- 2.8.1 Foundation Medicine Details
- 2.8.2 Foundation Medicine Major Business
- 2.8.3 Foundation Medicine Multi-Cancer Detection Blood Test Product and Services
- 2.8.4 Foundation Medicine Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Foundation Medicine Recent Developments/Updates
- 2.9 GENECAST
- 2.9.1 GENECAST Details
- 2.9.2 GENECAST Major Business
- 2.9.3 GENECAST Multi-Cancer Detection Blood Test Product and Services
- 2.9.4 GENECAST Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 GENECAST Recent Developments/Updates
- 2.10 Coyne Medical
- 2.10.1 Coyne Medical Details
- 2.10.2 Coyne Medical Major Business
- 2.10.3 Coyne Medical Multi-Cancer Detection Blood Test Product and Services
- 2.10.4 Coyne Medical Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Coyne Medical Recent Developments/Updates
- 2.11 Laboratory for Advanced Medicine
- 2.11.1 Laboratory for Advanced Medicine Details
- 2.11.2 Laboratory for Advanced Medicine Major Business
- 2.11.3 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product and Services
- 2.11.4 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Laboratory for Advanced Medicine Recent Developments/Updates
- 2.12 Singlera Genomics
- 2.12.1 Singlera Genomics Details
- 2.12.2 Singlera Genomics Major Business
- 2.12.3 Singlera Genomics Multi-Cancer Detection Blood Test Product and Services
- 2.12.4 Singlera Genomics Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Singlera Genomics Recent Developments/Updates
3 Competitive Environment: Multi-Cancer Detection Blood Test by Manufacturer
- 3.1 Global Multi-Cancer Detection Blood Test Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Multi-Cancer Detection Blood Test Revenue by Manufacturer (2018-2023)
- 3.3 Global Multi-Cancer Detection Blood Test Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Multi-Cancer Detection Blood Test by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Multi-Cancer Detection Blood Test Manufacturer Market Share in 2022
- 3.4.2 Top 6 Multi-Cancer Detection Blood Test Manufacturer Market Share in 2022
- 3.5 Multi-Cancer Detection Blood Test Market: Overall Company Footprint Analysis
- 3.5.1 Multi-Cancer Detection Blood Test Market: Region Footprint
- 3.5.2 Multi-Cancer Detection Blood Test Market: Company Product Type Footprint
- 3.5.3 Multi-Cancer Detection Blood Test Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Multi-Cancer Detection Blood Test Market Size by Region
- 4.1.1 Global Multi-Cancer Detection Blood Test Sales Quantity by Region (2018-2029)
- 4.1.2 Global Multi-Cancer Detection Blood Test Consumption Value by Region (2018-2029)
- 4.1.3 Global Multi-Cancer Detection Blood Test Average Price by Region (2018-2029)
- 4.2 North America Multi-Cancer Detection Blood Test Consumption Value (2018-2029)
- 4.3 Europe Multi-Cancer Detection Blood Test Consumption Value (2018-2029)
- 4.4 Asia-Pacific Multi-Cancer Detection Blood Test Consumption Value (2018-2029)
- 4.5 South America Multi-Cancer Detection Blood Test Consumption Value (2018-2029)
- 4.6 Middle East and Africa Multi-Cancer Detection Blood Test Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Multi-Cancer Detection Blood Test Sales Quantity by Type (2018-2029)
- 5.2 Global Multi-Cancer Detection Blood Test Consumption Value by Type (2018-2029)
- 5.3 Global Multi-Cancer Detection Blood Test Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Multi-Cancer Detection Blood Test Sales Quantity by Application (2018-2029)
- 6.2 Global Multi-Cancer Detection Blood Test Consumption Value by Application (2018-2029)
- 6.3 Global Multi-Cancer Detection Blood Test Average Price by Application (2018-2029)
7 North America
- 7.1 North America Multi-Cancer Detection Blood Test Sales Quantity by Type (2018-2029)
- 7.2 North America Multi-Cancer Detection Blood Test Sales Quantity by Application (2018-2029)
- 7.3 North America Multi-Cancer Detection Blood Test Market Size by Country
- 7.3.1 North America Multi-Cancer Detection Blood Test Sales Quantity by Country (2018-2029)
- 7.3.2 North America Multi-Cancer Detection Blood Test Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Multi-Cancer Detection Blood Test Sales Quantity by Type (2018-2029)
- 8.2 Europe Multi-Cancer Detection Blood Test Sales Quantity by Application (2018-2029)
- 8.3 Europe Multi-Cancer Detection Blood Test Market Size by Country
- 8.3.1 Europe Multi-Cancer Detection Blood Test Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Multi-Cancer Detection Blood Test Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Multi-Cancer Detection Blood Test Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Multi-Cancer Detection Blood Test Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Multi-Cancer Detection Blood Test Market Size by Region
- 9.3.1 Asia-Pacific Multi-Cancer Detection Blood Test Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Multi-Cancer Detection Blood Test Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Multi-Cancer Detection Blood Test Sales Quantity by Type (2018-2029)
- 10.2 South America Multi-Cancer Detection Blood Test Sales Quantity by Application (2018-2029)
- 10.3 South America Multi-Cancer Detection Blood Test Market Size by Country
- 10.3.1 South America Multi-Cancer Detection Blood Test Sales Quantity by Country (2018-2029)
- 10.3.2 South America Multi-Cancer Detection Blood Test Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Multi-Cancer Detection Blood Test Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Multi-Cancer Detection Blood Test Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Multi-Cancer Detection Blood Test Market Size by Country
- 11.3.1 Middle East & Africa Multi-Cancer Detection Blood Test Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Multi-Cancer Detection Blood Test Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Multi-Cancer Detection Blood Test Market Drivers
- 12.2 Multi-Cancer Detection Blood Test Market Restraints
- 12.3 Multi-Cancer Detection Blood Test Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Multi-Cancer Detection Blood Test and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Multi-Cancer Detection Blood Test
- 13.3 Multi-Cancer Detection Blood Test Production Process
- 13.4 Multi-Cancer Detection Blood Test Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Multi-Cancer Detection Blood Test Typical Distributors
- 14.3 Multi-Cancer Detection Blood Test Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Multi-Cancer Detection Blood Test. Industry analysis & Market Report on Multi-Cancer Detection Blood Test is a syndicated market report, published as Global Multi-Cancer Detection Blood Test Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Multi-Cancer Detection Blood Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
